Rafferty Asset Management, LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,631,403
-31.5%
98,159
-22.9%
0.01%
-23.1%
Q2 2023$2,380,641
+16.4%
127,307
+14.2%
0.01%
-7.1%
Q1 2023$2,044,924
-29.3%
111,440
-23.8%
0.01%
-41.7%
Q4 2022$2,894,166
+69.0%
146,170
+105.3%
0.02%
+33.3%
Q3 2022$1,713,000
-7.0%
71,210
-15.0%
0.02%
+63.6%
Q1 2022$1,841,000
-40.4%
83,733
-0.5%
0.01%
-31.2%
Q4 2021$3,090,00084,1330.02%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$49,189,39517.79%
Euclidean Capital LLC 432,900$7,943,7156.97%
GREAT POINT PARTNERS LLC 1,355,151$24,867,0214.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 875,984$16,074,3063.02%
Trustees of Columbia University in the City of New York 80,580$1,478,6432.64%
Perceptive Advisors 2,291,608$42,051,0071.24%
Cormorant Asset Management, LP 650,000$11,9280.79%
Alphabet Inc. 540,270$9,913,9550.55%
Redmile Group, LLC 688,132$12,627,2220.55%
Orbimed Advisors 1,251,070$22,957,1350.45%
View complete list of RAPT THERAPEUTICS INC shareholders